Suppr超能文献

肝细胞癌根治性切除或射频消融术后原发性肝移植与挽救性肝移植:长期肿瘤学结局

Primary versus Salvage Liver Transplantation after Curative-Intent Resection or Radiofrequency Ablation for Hepatocellular Carcinoma: Long-Term Oncological Outcomes.

作者信息

Anselmo Alessandro, Siragusa Leandro, Brigato Paolo, Riccetti Camilla, Collini Andrea, Sensi Bruno, Tisone Giuseppe

机构信息

Department of Surgical Sciences, Hepatobiliary and Transplant Unit, Policlinico Tor Vergata, 00133 Rome, Italy.

Department of Surgical Science, University of Rome "Tor Vergata", 00133 Rome, Italy.

出版信息

Cancers (Basel). 2023 Oct 18;15(20):5030. doi: 10.3390/cancers15205030.

Abstract

Liver transplantation for hepatocellular carcinoma (HCC) may be performed ab initio, primary liver transplantation (PLT), or for HCC recurrence after previous treatments such as liver resection (LR) or radiofrequency ablation (RFA), salvage liver transplantation (SLT). The aim of this study was to evaluate the oncological outcomes of SLT vs. PLT. For this, a retrospective study was carried out on patients undergoing liver transplantation for HCC. The outcomes of PLT were compared with those of SLT. The primary outcome was disease-free survival (DFS). The secondary outcomes included overall survival (OS), cancer-specific survival (CSS), and major postoperative complications. A sub-analysis of SLT-LR and SLT-RFA was also performed. In total, 141 patients were included: 96 underwent PLT and 45 SLT. Among the SLT group, 25 patients had undergone previous LR while 20 had had RFA. There were no differences in the major postoperative complications. Unadjusted DFS was significantly longer in the PLT group ( = 0.02), as were OS ( = 0.025) and CSS ( = 0.001). There was no difference in DFS between PLT and SLT-LR groups, while a significant difference was found between the PLT and SLT-RFA groups ( = 0.035). Nonetheless, DFS was no different between the SLT-LR and SLT-RFA groups. PLT appears to offer superior long-term oncological outcomes to SLT. Both SLT-LR and SLT-RFA offer acceptable OS and CSS. Further prospective studies are needed to confirm these results, but the re-direction of grafts and transplant philosophy towards PLT rather than SLT may need to be considered.

摘要

肝细胞癌(HCC)的肝移植可以一开始就进行,即原发性肝移植(PLT),也可以用于先前治疗(如肝切除术(LR)或射频消融(RFA))后HCC复发时的挽救性肝移植(SLT)。本研究的目的是评估SLT与PLT的肿瘤学结局。为此,对接受HCC肝移植的患者进行了一项回顾性研究。将PLT的结局与SLT的结局进行比较。主要结局是无病生存期(DFS)。次要结局包括总生存期(OS)、癌症特异性生存期(CSS)和主要术后并发症。还对SLT-LR和SLT-RFA进行了亚组分析。总共纳入了141例患者:96例行PLT,45例行SLT。在SLT组中,25例患者先前接受过LR,20例接受过RFA。主要术后并发症方面无差异。PLT组的未调整DFS显著更长(=0.02),OS(=0.025)和CSS(=0.001)也是如此。PLT组和SLT-LR组之间的DFS无差异,而PLT组和SLT-RFA组之间存在显著差异(=0.035)。尽管如此,SLT-LR组和SLT-RFA组之间的DFS无差异。PLT似乎比SLT具有更好的长期肿瘤学结局。SLT-LR和SLT-RFA均提供可接受的OS和CSS。需要进一步的前瞻性研究来证实这些结果,但可能需要考虑将移植物和移植理念转向PLT而非SLT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/280b/10605470/b2f363fa7529/cancers-15-05030-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验